• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Lotronex (alosetron hydrochloride) Tablets

[UPDATE November 29, 2000] Glaxo Wellcome withdraws Lotronex tablets from the market.

New safety information and labeling changes for Lotronex. This new information pertains to reports of constipation, that in a few cases have resulted in serious sequelae and infrequent reports of ischemic colitis occurring in association with the use of Lotronex.

[August 24, 2000 - Health Professional Letter - GlaxoWellcome, Inc]
[August 24, 2000 - Pharmacist Letter - GlaxoWellcome, Inc]
[November 29, 2000 - Questions and Answers - FDA]